ArticleFrontiers in immunology2026
From tissue to blood: an integrated multi-omics signature identifies fibrogenesis and neutrophil activation as key drivers of ulcerative colitis severity.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ulcerative colitis (UC) is an idiopathic chronic inflammatory disease of the colon characterized by severe disease burden and multiple co-morbidities. Currently, the endoscopic Mayo score is considered the gold standard for assessing disease severity in UC. However, the molecular mechanisms underlying severity are still poorly understood. This study aimed to better understand the molecular alterations associated with severity in UC. To achieve this goal, gene expression and DNA methylation were measured in paired blood and colonic tissue samples from UC patients at different severity stages. Methods: Differential gene expression and methyl-ation analyses, as well as integrative multi-omics network analysis including both omics layers and tissues were performed. A hybrid framework combining prior knowledge and text-mining was deployed to contextualize the associations retrieved from the multi-omics network. Results: Our analyses suggested that mild UC was associated with molecular alterations affecting mainly the colon, while severe UC had systemic consequences. Moreover, the combination of the differentially expressed genes and methylated regions found in blood and colonic tissue allowed us to suggest potential associations between them and formulate hypothesis on novel mechanisms associated with different UC severity stages. Discussion: Among them, fibrogenesis, colonic epithelial cell death, and Tuft cell-related processes seemed to be associated with milder disease stages. In contrast, neutrophil-driven innate immune response and complex B cell and CD4 T cell interactions were suggested as potential mechanisms involved in severe UC. Finally, the findings of this study led to the formulation of a hypothesis suggesting that impaired PPARG anti-inflammatory regulation associated with colonic LCN2 activity might play a relevant role in UC severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.